BEIJING, May 17 /PRNewswire-Asia/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM), an emerging leader in the development, assembly, marketing and sale of medical products in China, said today that it has become the exclusive China distributor of Welch Allyn's patient monitors.
(Logo: http://www.prnasia.com/sa/2010/04/22/2010042280488.jpg )
Welch Allyn's two patient monitors, the Propaq(R)CS and the Atlas(TM), are used for continuous bedside monitoring of vital signs such as ECG, NIBP, temperature, respiratory functions, blood pressure and other indications.
In addition, Dehaier is also the distributor of Welch Allyn's eye, ears, nose and throat products including otoscopes, ophthalmoscopes and laryngoscopes.
Mr. Chen Ping, Dehaier's Chief Executive Officer, said, "One of Dehaier's key strategies for continued revenue growth in our medical device product line is to continue to penetrate markets by introducing advanced new product offerings. This agreement with Welch Allyn is an important opportunity that provides us with access to the market segment for foreign-made patient monitors, which we estimate to be about $30 million per year. Dehaier is currently a provider of Chinese-made patient monitoring devices, a growing market that is estimated to exceed $300 million per year."
"This agreement enables us to strongly supplement our product lines to meet different demands from hospitals, medical centers and doctors. It is further evidence of our strong industry reputation that a leading medical manufacturer like Welch Allyn would entrust Dehaier with their China sales and distribution," Ping said.
About Welch Allyn
Welch Allyn, Inc., headquartered in Skaneateles Falls, New York, is a leading worldwide manufacturer of innovative diagnostic and therapeutic devices, cardiac defibrillators, patient monitoring systems and miniature precision lamps. Welch Allyn employs more than 2,500 people and has numerous manufacturing, sales, and distribution facilities located in 26 different countries. Learn more at http://www.welchallyn.com
About Dehaier Medical Systems Ltd.
Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare products. The company develops and assembles its own branded products from third party components. The company also distributes products designed and manufactured by other companies including medical devices and respiratory and oxygen homecare products from IMD (Italy), Timesco (UK), ResMed (Australia) and JMS (Japan). Dehaier's technology is based on two patents, five pending patents and proprietary technology. More information may be found at http://www.chinadhr.com .
Information for investors, including an investment profile about Dehaier is available at http://www.hawkassociates.com/profile/dhrm.cfm . An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors is available at http://www.hawkassociates.com .
Forward-looking Statements
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Investor contact:
Hawk Associates
Julie Marshall or Frank Hawkins
Tel: +1-305-451-1888
Email: dehaier@hawkassociates.com
